Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
60.73
-2.02 (-3.22%)
At close: Oct 12, 2026, 4:00 PM EDT
60.75
+0.02 (0.03%)
After-hours: Oct 12, 2026, 7:30 PM EDT
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of $8.58 billion as of October 12, 2026. It is the 2,392nd most valuable company in the world and the 829th biggest in the United States. Its market cap has increased by 75.22% in one year.
Market Cap
8.58B
Enterprise Value
8.36B
1-Year Change
75.22%
Global Rank
Country Rank
#829 United States
Category
ChartMarket Cap Chart
Since January 15, 2004, Arrowhead Pharmaceuticals's market cap has increased from $300.00K to $8.58B, an increase of 2,859,361.26%. That is a compound annual growth rate of 56.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 8.58B | -4.86% |
| Dec 31, 2025 | 9.02B | 285.42% |
| Dec 31, 2024 | 2.34B | -28.84% |
| Dec 29, 2023 | 3.29B | -23.54% |
| Dec 30, 2022 | 4.30B | -37.84% |
| Dec 31, 2021 | 6.92B | -11.95% |
| Dec 31, 2020 | 7.86B | 29.67% |
| Dec 31, 2019 | 6.06B | 451.13% |
| Dec 31, 2018 | 1.10B | 299.42% |
| Dec 29, 2017 | 275.20M | 154.58% |
| Dec 30, 2016 | 108.10M | -70.48% |
| Dec 31, 2015 | 366.20M | -9.27% |
| Dec 31, 2014 | 403.60M | -3.88% |
| Dec 31, 2013 | 419.90M | 1,153.43% |
| Dec 31, 2012 | 33.50M | -24.04% |
| Dec 30, 2011 | 44.10M | -31.42% |
| Dec 31, 2010 | 64.30M | 93.09% |
| Dec 31, 2009 | 33.30M | -15.70% |
| Dec 31, 2008 | 39.50M | -72.93% |
| Dec 31, 2007 | 145.90M | -2.60% |
| Dec 29, 2006 | 149.80M | 25.99% |
| Dec 30, 2005 | 118.90M | 101.87% |
| Dec 31, 2004 | 58.90M | 19,533.33% |
| Jan 15, 2004 | 300.00K | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Twist Bioscience | 10.02B |
| Krystal Biotech | 9.82B |
| Kymera Therapeutics | 9.35B |
| Protagonist Therapeutics | 9.30B |
| Axsome Therapeutics | 8.82B |
| Cytokinetics | 8.75B |
| Caris Life Sciences | 8.39B |
| Spyre Therapeutics | 8.01B |